Mutual Funds
Nippon India Pharma Fund(G)
Equity  |   Very High  |   Equity - Sectoral Fund - Pharma & Health Care
497.01   +5.49
NAV(₹) as on 20/3/2026 		1.12%
  1D 		2.63%
  1Y 		23.09%
  3Y 		15.57%
  5Y
Nippon India Pharma Fund(G)
Growth Chart of the Scheme

Scheme Details
Expense Ratio:
1.81 		Launch Date:
05 Jun 2004
Exit Load:
1% on or before 1M, Nil after 1M 		AUM:
₹ 8,306.35 Crs
Lock-in:
Nil 		Investing Style:
Large Growth
Portfolio Price To Book Value:
7.56 		Min. Investment:
SIP : ₹ 100.00
Lumpsum : ₹ 5,000.00
Scheme Benchmark:
NA
Fund Manager:
Sailesh Raj Bhan

FUND OBJECTIVE

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

LATEST ASSET & PORTFOLIO ALLOCATION Others Equity
as on 28/2/2026 0.30 % 99.70 %
TOP HOLDINGS

Sun Pharmaceutical Industries Ltd.
13.08 %

Lupin Ltd.
7.99 %

Divi's Laboratories Ltd.
6.56 %

Dr. Reddy's Laboratories Ltd.
5.81 %

Cipla Ltd.
5.67 %

Apollo Hospitals Enterprise Ltd.
5.17 %

Medplus Health Services Ltd.
3.70 %

Max Healthcare Institute Ltd.
3.49 %

Vijaya Diagnostic Centre Ltd.
3.49 %

Ajanta Pharma Ltd.
3.41 %

See All Holding
ALLOCATION BY MARKET CAP (Equity)
ALLOCATION BY RATING (Debt & Others)

No Data

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs
74.41 %

Hospital & Healthcare Servic
20.63 %

Retailing
3.70 %

Business Support
0.96 %

See All Sectors
PORTFOLIO CHARACTERISTICS (Debt)

No Data

5 YEAR HISTORY

Financial Year 2021-22 2022-23 2023-24 2024-25 2025-26
NAV (20/3/2026) 290.14 270.59 428.87 481.27 497.01
Net Assets (Rs Crores) 4,93,188.52 4,30,446.45 7,12,528.46 8,08,096.99 8,30,634.97
Scheme Returns(%)(Absolute) 14.83 -6.85 58.24 10.94 4.84
B'mark Returns(%)(Absolute) NA NA NA NA NA
Category Rank 43/75 65/76 17/90 30/102 32/119
RISKOMETER
Level of Risk in the Scheme

Clients will understand that their principal will be at Very High risk.

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Fund Details Inception Date Aum(₹ Crs) 1Y 3Y 5Y Since Inception
MDB Logo
Kotak Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  13.34   +0.22  
11/12/2023 ₹ 485.24 4.33% - - 13.49%
MDB Logo
Quant Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  14.33   +0.16  
17/7/2023 ₹ 350.44 1.09% - - 14.39%
MDB Logo
HDFC Pharma and Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  17.00   +0.19  
4/10/2023 ₹ 2,030.81 6.69% - - 24.24%
MDB Logo
WOC Pharma and Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  13.61   +0.23  
6/2/2024 ₹ 533.05 6.83% - - 15.67%
MDB Logo
PGIM India Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  9.70   +0.07  
6/12/2024 ₹ 92.45 4.30% - - -2.34%
MDB Logo
Bajaj Finserv Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  9.16   +0.11  
27/12/2024 ₹ 314.74 1.04% - - -6.91%
MDB Logo
Baroda BNP Paribas Health and Wellness Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  9.17   +0.09  
27/6/2025 ₹ 564.85 - - - -8.29%
MDB Logo
Bandhan Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  9.35   +0.11  
28/11/2025 ₹ 294.7 - - - -6.49%
MDB Logo
ITI Pharma & Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  14.95   +0.21  
8/11/2021 ₹ 221.78 -4.23% 19.52% - 9.65%
MDB Logo
DSP Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  36.42   +0.31  
30/11/2018 ₹ 3,033.42 -2.90% 20.93% 14.44% 19.35%